findmyKOL

Megan Coylewright, MD

Enriched profile

Interventional Cardiology

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Calhoun, GA · Southeast · United StatesSpecialtyInterventional CardiologyFocusHeart Failure
Active KOLfindmyKOL type: EliteLatest publication2022Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Megan Coylewright is a Heart Failure physician. OpenAlex indexes 168 publications with 2,976 citations (h-index 30); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 16 Oct 2026

Megan Coylewright, MD, is profiled from the public federal record. The public record shows 168 publications with 2,976 citations (h-index 30), centered on Heart Failure. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 20 companies.

  • Most recent indexed publication: 2022 · Journal of the American Heart Association
  • Top research focus: Heart Failure
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 20 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Heart Failure1 trialHypertension1 trialCardiovascular Diseases1 trialVascular Diseases1 trial

Research focus

OpenAlex concept fingerprint
Heart Failure

Drugs & molecules

across trials, industry payments and publications
Camzyosgeneric · MavacamtenClinical trials—Industry payments1Publications—Cleviprexgeneric · ClevidipineClinical trials—Industry payments1Publications—Injectafergeneric · Ferric carboxymaltoseClinical trials—Industry payments1Publications—Jardiancegeneric · EmpagliflozinClinical trials—Industry payments1Publications—Kengrealgeneric · CangrelorClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
ReCor Medical, Inc.Clinical trials1Industry payments6Boston Scientific CorporationClinical trials—Industry payments172Edwards Lifesciences CorporationClinical trials—Industry payments72Medtronic, Inc.Clinical trials—Industry payments44Abbott LaboratoriesClinical trials—Industry payments40ShockWave Medical, IncClinical trials—Industry payments3AbiomedClinical trials—Industry payments2Atricure, Inc.Clinical trials—Industry payments2Siemens Medical Solutions USA, Inc.Clinical trials—Industry payments2ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Clinical trials—Industry payments2Acist Medical Systems, Inc.Clinical trials—Industry payments1Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments1Chiesi USA, Inc.Clinical trials—Industry payments1Daiichi Sankyo Inc.Clinical trials—Industry payments1E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments1Occlutech International ABClinical trials1Industry payments—Philips Electronics North America CorporationClinical trials—Industry payments1Sanofi-Aventis U.S. LLCClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
168publications

Distinct works indexed by OpenAlex, matched via ORCID; 3 in PubMed.

2,976citations

Total citations across indexed works.

30h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
20companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 16 Oct 2026

20 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    100%
    Calcium channel blocker55.6%
    Amlodipine Besylate100%
    Part D<11 patients
    Beta blocker44.4%
    Metoprolol Succinate100%
    Part D<11 patients
Where care is delivered (Part B), 202364.6% facility · 35.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 16 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/megan-coylewright-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/in/megan-coylewright-3953a0201

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • X / Twitter

    x.com/MCoylewright

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • Other

    erlangerhealth.wordpress.com/2021/02/18/erlanger-welcomes-structural-interventional-cardiologist-dr-megan-coylewright

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →erlangerhealth.wordpress.com ↗
  • Other

    acc.org/latest-in-cardiology/articles/2021/09/16/13/41/megan-coylewright-named-editor-of-cardiosmart

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acc.org ↗
  • Other

    scai.org/megan-coylewright-md-fscai

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scai.org ↗
  • YouTube

    youtube.com/shorts/6wAV0HjnF3I

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.